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INTRODUCTION
During metazoan development, embryonic cells must select from
among multiple possible fates, and, ultimately, their descendants
will produce gene products typical of a differentiated tissue. In the
nematode C. elegans, early embryonic cells acquire transient,
distinct identities after the zygote undergoes a series of
asymmetrical cleavages. These form the six so-called ‘founder
cells’, each of which undergoes a stereotyped pattern of cell
divisions to give rise to a nearly invariant set of descendants (Fig.
1A) (Sulston et al., 1983). The emergent paradigm of
blastomere/lineage specification is that maternal factors first
specify blastomere identity by zygotic activation of blastomere-
specific factors, which ultimately leads to activation of tissue-
specific gene networks (Labouesse and Mango, 1999; Lei et al.,
2009; Maduro, 2009). Blastomere-specific factors are transiently
expressed and act for a short time in development, whereas tissue-
specific factors tend to maintain their expression throughout the
lifespan. An understanding of how lineage-specific activation of
tissue factors is achieved will close the gap between studies of
blastomere fate and studies of tissue identity, generating a
comprehensive gene network that describes development.
The 7-cell stage MS blastomere generates many mesodermal
cell types, including cells of the pharynx and body musculature
(Fig. 1A,C). The gene cascade that specifies MS has been studied
for almost two decades (Fig. 1B). Initial specification of MS
requires maternal activity of the bZIP/homeodomain factor SKN-
1 (Bowerman et al., 1993; Bowerman et al., 1992). Loss of skn-1
leads to a lack of MS-derived tissues and a somewhat less
penetrant loss of endoderm from E, the sister cell of MS
(Bowerman et al., 1992). skn-1 mutants also lack the AB-derived
portion of the pharynx owing to failure of a Notch/GLP-1-
mediated induction from MS to the AB lineage (Priess et al., 1987;
Shelton and Bowerman, 1996). In skn-1 mutants, mis-specified
MS and E cells adopt the fate of the mesectodermal precursor C
(Bowerman et al., 1992). In EMS (the mother of MS and E), SKN-
1 activates the zygotic med-1 med-2 (med-1,2) divergent GATA
factor gene pair (Coroian et al., 2005; Maduro et al., 2001). Loss
of med-1,2 has a similar effect on MS specification as loss of skn-
1, but a much weaker effect on E specification owing to parallel
contributions to endoderm from SKN-1 and other factors
(Goszczynski and McGhee, 2005; Maduro et al., 2005a; Maduro
et al., 2001). In MS, MED-1,2 activate the T-box factor gene tbx-
35 (Broitman-Maduro et al., 2006). Loss of tbx-35 has variable
effects on MS lineage development and morphogenesis, although
the most severely affected mutants resemble skn-1 or med-1,2
embryos and lack most tissues made by MS (Broitman-Maduro et
al., 2006).
The regulatory cascade initiated by SKN-1 works
combinatorially with other factors that restrict MS fate to the
appropriate blastomere. Within the EMS lineage, SKN-1 and its
target genes collaborate with the Wnt/β-catenin asymmetry
pathway to distinguish MS and E identity (Maduro et al., 2002;
Rocheleau et al., 1997; Shetty et al., 2005; Thorpe et al., 1997).
EMS receives an induction from its posterior sister P2 that
ultimately results in differential nucleocytoplasmic localization of
the nuclear effector TCF/POP-1 within MS and E, referred to as
POP-1 asymmetry (Goldstein, 1992; Lin et al., 1998; Lo et al.,
2004; Maduro et al., 2005a; Rocheleau et al., 1999). Within the E
cell, reduced nuclear POP-1 permits POP-1 to function as an
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endoderm activator through association with the divergent β-
catenin SYS-1 (Huang et al., 2007; Phillips et al., 2007). Blockage
of the induction, or of the components that act upstream of POP-1,
results in EMS dividing to produce two MS-like cells (Goldstein,
1992; Rocheleau et al., 1997; Rocheleau et al., 1999; Thorpe et al.,
1997). Outside of the EMS lineage, multiple factors block
inappropriate expression of SKN-1 or prevent its timely
degradation, either of which can otherwise lead to ectopic mis-
specification of MS or E fates (Lin, 2003; Mello et al., 1992; Page
et al., 2007; Shirayama et al., 2006).
The organ-identity factors that specify the two major tissues made
by MS, pharynx and muscle, have been well characterized. Pharynx
is specified by FoxA/PHA-4 (Horner et al., 1998; Kalb et al., 1998),
which is at the top of a network of at least several hundred genes
(Gaudet and Mango, 2002) that includes the pharynx muscle-
specific gene ceh-22 (Okkema and Fire, 1994). Body muscle is
specified by the activity of three regulators, MyoD/HLH-1,
HAND/HND-1 and SRF/UNC-120 (Fukushige et al., 2006). All
three genes have overlapping function, as each can specify muscle
fate when overexpressed and muscle specification is blocked only
when the activity of all three has been compromised (Fukushige et
al., 2006). Approximately 1300 genes are known to be enriched for
expression in muscle (Fox et al., 2007), suggesting that HLH-1,
HND-1 and UNC-120 are at the top of a complex tissue-specific
muscle gene network.
In the present study we identify the NK-2 homeobox gene ceh-51
as a direct target of TBX-35, and present evidence that CEH-51 and
TBX-35 have distinct and shared functions. Whereas loss of ceh-51
function causes subtle muscle and pharynx defects and larval
lethality, simultaneous loss of ceh-51 and tbx-35 results in a highly
penetrant loss of MS-derived tissues and an embryonic arrest
phenotype that is strikingly similar to that of med-1,2(–) embryos,
thus explaining the weaker phenotype of single tbx-35 mutants. Our
results add an important regulator, CEH-51, to the MS gene
regulatory network, and suggest that combinatorial control of
mesoderm through T-box and NK-2 factors has been evolutionarily
conserved.
MATERIALS AND METHODS
Strains used
C. elegans animals were cultured on E. coli OP50 using standard methods
(Sulston and Hodgkin, 1988). The wild-type strain was N2. Mutations: LG
X: hnd-1(q740), med-1(ok804). LG I: unc-120(st364). LG II: tbx-
35(tm1789), hlh-1(cc561ts). LG III: unc-119(ed4), med-2(cx9744). LG IV:
skn-1(zu67). LG V: ceh-51(tm2123). Rearrangement: nT1 [unc-?(n754) let-
?](IV;V). Transgenes: gvIs401 V [unc-120::GFP], gvIs402 I [unc-120::GFP],
cuIs1 V [ceh-22::GFP], ccIs7963 V [hlh-1::GFP], qIs55 [hnd-1::GFP], irIs57
III [hs-ceh-51], irIs70 [hs-ceh-51], cdIs41 II [cup-4::GFP], cdIs42 I [cup-
4::GFP], ruIs37 III [myo-2::GFP], pxIs[pha-4::GFP] IV, irIs39 III [ceh-
51::GFP], irIs41 [ceh-51::GFP], irIs42 X [hs-tbx-35], irIs58 [hs-ceh-51],
irIs89 [ceh-51(+)], qtIs9 [nhr-25::YFP]. We have previously observed a lack
of strict additivity and variability in the number of cells expressing tissue-
specific reporters (Lin et al., 2009). We attribute this primarily to expression
mosaicism between animals and the difficulty of resolving adjacent cells.
Identification of ceh-51
Y80D3A.3 (previously dlx-1) was named ceh-51 in consultation with
Thomas Burglin and Jonathan Hodgkin (Karolinska Institute, Stockholm,
Sweden and University of Oxford, Oxford, UK). ceh-51 resides within
intron 12 of Y80D3A.2/emb-4 (WormBase, WS200 release). Four ESTs
support a single transcript with one intron for ceh-51 that does not overlap
emb-4 exonic sequences (Kohara, 2001). As RNAi targeted to introns does
not affect mature transcripts (Fire et al., 1998), it is unlikely that RNAi
targeted to ceh-51 would affect transcripts of emb-4. Indeed, RNAi of emb-
4 results in embryonic lethality (Katic and Greenwald, 2006), not larval
arrest (see text).
Construction of ceh-51(tm2123) strains
We injected a heterozygous ceh-51(tm2123) strain (a gift from Shohei
Mitani, National Bioresource Project, Japan) with overlapping genomic
PCR products spanning the ceh-51 locus (but lacking any exonic emb-4
sequences; primer sites are shown in Fig. 2) and an unc-119::CFP reporter
(pMM809) to produce MS1206, a line that segregated arrested larvae and
unc-119::CFP(+) viables. We confirmed the correct splicing of emb-4 in the
tm2123 strain by RT-PCR. After backcrossing, the array was replaced with
another carrying ceh-51(+), unc-119::mCherry (pMM824) and myo-
2::mCherry (pCFJ90) for the muscle phenotype synergy experiments. PCR
confirmed homozygosity of the tm2123 deletion in this strain. A
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Fig. 1. Developmental context of the MS
lineage and its gene regulatory network.
(A) Partial cell lineage showing the production of
major tissue types (number of cells in brackets) from
early blastomeres (Sulston et al., 1983). The MS
lineage is expanded to show the origin of pharynx,
muscle and coelomocytes. (B) Gene regulatory
network for MS specification [modified with
permission from Maduro (Maduro, 2009)].
(C) Embryo stages. Blastomeres are indicated on the
8-cell stage embryo. In the 1.5-fold embryo, all
pharynx nuclei, and body muscle nuclei of the left
half of the embryo, are shown. Darker-shaded nuclei
are those derived from MS. The left-side embryonic
coelomocytes (cc) are shown as circles with an X. For
the L1 larva, tissues are indicated along with their
blastomere of origin. A C. elegans embryo is ~50μm
long. Here and in subsequent figures, anterior is to
the left and dorsal is up.
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spontaneous integrant of a ceh-51(+) array, irIs89, showed that 96% (n=253)
of ceh-51(tm2123); irIs89 embryos were rescued to full viability. A tbx-
35(tm1789); ceh-51(tm2123) double mutant strain was made by crossing
tbx-35; Ex[tbx-35(+), unc-119::YFP] males to ceh-51; Ex[ceh-51(+), unc-
119::CFP] hermaphrodites, and identifying YFP/CFP-expressing F2 animals
that gave arrested embryos/larvae and in which all viable animals expressed
both YFP and CFP. The two arrays in MS1275 were replaced by a single
array marked with unc-119::mCherry (pMM824) or sur-5::dsRed (pAS152).
Cloning and transgenics
To construct ceh-51::GFP (pGB196), a PCR product containing 788 bp
upstream of the ceh-51 start codon and 204 bp of the coding region was
cloned into the SphI-BamHI sites in pPD95.67. A smaller reporter, with 187
bp of upstream DNA and 5 bp of coding region, was cloned similarly
(pWH270). TBX-35 sites were mutated into restriction sites by PCR in
pWH270. A translational fusion was constructed by combining 358 bp of
ceh-51 promoter, a GFP coding region from pPD95.67 and the genomic
region of ceh-51 containing the exons, intron and 3UTR. A heat-shock ceh-
51 construct was created by cloning the coding region, intron and 468 bp of
the 3UTR into pPD49.78. Further PCR and cloning details are available on
request. Transgenics and integrants were made as described (Maduro et al.,
2001).
RNAi experiments
For feeding-induced RNAi, L4 animals were fed for 36 hours on E. coli
HT115 from the OpenBioSystems RNAi Library or transformed with clones
made in pPD129.36. Adults were transferred to fresh plates for egg laying
for 4-6 hours at 25°C. Embryos were allowed to develop for 12-24 hours
prior to scoring. For dsRNA synthesis, PCR products carrying the T7 RNA
polymerase recognition sequence at each end were amplified from N2 DNA,
cDNA clones or the Ahringer Lab RNAi Library (Kamath and Ahringer,
2003). dsRNA was synthesized using the Ambion MEGAscript T7 Kit and
microinjected into late L4 worms or young adults as described (Ahringer,
2006). Injected animals were allowed to recover for 3-24 hours and
transferred to fresh plates for egg laying.
In situ hybridization
Embryos were stained as described (Coroian et al., 2005). For pal-1 staining
of med-1,2 and ceh-51; tbx-35 embryos, a mixture of rescued and non-
rescued embryos were stained, and the number of mutants was estimated
from the array transmission frequency.
Phalloidin staining
Embryos or larvae were freeze-cracked on dry ice or frozen in liquid
nitrogen, fixed in 4% formaldehyde and stained with Alexa Fluor 488-
conjugated phalloidin (Molecular Probes, Eugene, OR, USA) as described
(Shaham, 2006).
Laser ablation, microscopy and imaging
Laser ablations were performed as described (Lin et al., 2009). Animals
were imaged on a Zeiss Axioplan using a Hamamatsu ORCA II digital
camera, or on an Olympus BX-61 with a Canon 350D camera. For
phalloidin-stained larvae, a Zeiss LSM510 confocal microscope was used
(Microscopy and Imaging Core Facility, UC Riverside). Adobe Photoshop
7 and ImageJ v1.37 were used to adjust image brightness and generate
overlays.
Heat-shock experiments
Embryos were heat shocked as a group for 30-45 minutes at 33°C while they
were contained within hermaphrodite mothers, representing a
developmental time interval of 0-3 hours. After heat shock, hermaphrodites
were allowed to lay eggs for 3-4 hours. Embryos were allowed to develop
for a further 6-12 hours before scoring. For in situ hybridizations after heat
shock, mothers were left overnight at 15°C on plates without food.
Expression and purification of recombinant TBX-35
A cDNA fragment encoding amino acids 120-325, corresponding to the
predicted TBX-35 DNA-binding domain, was cloned into the GST vector
pGEX-4T-1 (GE Healthcare) to generate pWH173. This was transformed
into E. coli Rosetta2 cells (Novagen), grown at 37°C to an OD of 0.3, and
protein production was induced with 0.3 mM IPTG overnight at 25°C. Cells
were resuspended in BugBuster HT (Novagen) with one tablet of Complete,
Mini, EDTA-free Protease Inhibitor (Roche). Glutathione beads, swelled in
phosphate-buffered saline (PBS), were added to the lysate for 1 hour. After
three washes with PBS, the protein was eluted in 50 mM Tris-HCl (pH 7.5),
5 mM reduced glutathione, 80 mM NaCl, 0.03% Triton X-100, and desalted
using a P6 column (BioRad). The protein was stored at –20°C in 50%
glycerol with 1 mM DTT and 10 mM Tris (pH 7.5).
Gel shift and DNase I footprinting
EMSA probes were gel-purified PCR products generated with a 32P end-
labeled primer and an unlabeled primer. The probes contained DNA
corresponding to –187 bp to +5 bp relative to the ceh-51 ATG. Probes
carrying mutated sites were amplified from the corresponding GFP
reporters. Gel shift and DNase I footprinting were performed as previously
described for MED-1 (Broitman-Maduro et al., 2005), except that 10 μM
GST and 10, 25 and 50 μM GST::TBX-35(DBD) were used, 6% acrylamide
gels were run, and complexes were treated with 0.5 units of DNase I
(Epicentre) for 40 seconds prior to organic extraction. For competition
arrays, complementary oligonucleotides were annealed at 95°C for 5
minutes, cooled for 15 minutes and added to reactions at a 50-fold excess.
RESULTS
Identification of CEH-51, a putative NK-2 class
homeodomain transcription factor
Loss of med-1,2 leads to a highly expressive loss of MS-derived
tissues, whereas loss of tbx-35 has a less expressive MS phenotype,
especially at lower temperatures (Broitman-Maduro et al., 2006;
Maduro et al., 2001) (this work), suggesting that an additional factor
contributes to MS specification downstream of MED-1,2
(Broitman-Maduro et al., 2006). From embryonic transcriptome
analyses (Baugh et al., 2005; Baugh et al., 2003), we identified
Y80D3A.3 as a candidate early MS lineage gene. Transcripts were
reported to accumulate when the MS lineage is undergoing its first
divisions, and were reduced in mex-3(zu155); skn-1(RNAi) embryos,
which do not correctly specify MS. In parallel, we identified
Y80D3A.3 in an RNAi screen for enhancement of hlh-1(cc561ts)
muscle defects (S.K. and P.W.S., unpublished results).
The Y80D3A.3 gene encodes a putative homeodomain
transcription factor, CEH-51 (Fig. 2). Of the 89 homeodomain
proteins encoded by the C. elegans genome (Okkema and Krause,
2005), CEH-51 is most closely related to CEH-7 (Kagoshima et al.,
1999), CEH-24 (Harfe and Fire, 1998) and TAB-1 (CEH-29) [L.
Carnell and M. Chalfie, unpublished data cited in Syntichaki and
Tavernarakis (Syntichaki and Tavernarakis, 2004)], sharing 41-48%
identity (57-58% similarity) within the homeodomain (Fig. 2B,C).
The CEH-51 homeodomain is most closely related to those of NK-
2 subfamily proteins, with which it shares 39-43% identity (59-62%
similarity), although CEH-51 lacks the conserved tyrosine at
position 54 of the homeodomain (asterisk in Fig. 2C) that is typical
of NK-2 proteins (Harvey, 1996). The C. elegans pharynx muscle
NK-2 factor CEH-22 is more closely related to other NK-2 family
members, as it contains the conserved tyrosine and shares 85%
identity (90% similarity) with Drosophila Vnd/NK-2 across the
homeodomain. CEH-51 contains multiple serine residues in its N-
terminus (16/50 residues), a feature noted for the N-termini of CEH-
24 (Harfe and Fire, 1998) and the endoderm-specifying END-1,3
GATA factors (Maduro et al., 2005b).
ceh-51 is expressed in the early MS lineage
downstream of TBX-35
We confirmed that ceh-51 transcripts accumulate in the MS
daughters and persist into the MS granddaughters, as observed in
91% (n=70) of embryos at the MS2 to MS4 stage (Fig. 3A,B).
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Similar expression was seen with a ceh-51::GFP transcriptional
reporter carrying 788 bp of genomic DNA upstream of the predicted
ATG (Fig. 3E), a GFP::CEH-51 translational fusion with 358 bp of
upstream region (Fig. 3F), and from expression reported by others
(Hunt-Newbury et al., 2007; Kohara, 2001; Reece-Hoyes et al.,
2007). As anticipated by the mis-specification of MS in skn-1 and
med-1,2 mutant embryos (Bowerman et al., 1992; Maduro et al.,
2001), expression of ceh-51::GFP was not observed in these
backgrounds (Fig. 3G; data not shown). Conversely, ectopic ceh-
51::GFP was observed in mex-1 and pie-1 RNAi backgrounds (Fig.
3I,J), in which additional MS-like cells are made from the AB and
C lineages, respectively (Mello et al., 1992). We have previously
found that tbx-35 is still expressed in MS in a pop-1(RNAi)
background (Broitman-Maduro et al., 2006), even though in this
background MS adopts an E-like fate (Lin et al., 1995).
Unexpectedly, most pop-1(RNAi) embryos expressed ceh-51 in both
the MS and E lineages (Fig. 3D,H).
The expression pattern of ceh-51 suggests that it is a direct target
of TBX-35. Overexpression of TBX-35 was sufficient to cause
ectopic ceh-51 activation (Fig. 3C), whereas weaker expression still
occurred in approximately half of tbx-35(tm1789) mutants (Fig. 3K),
demonstrating that TBX-35 is sufficient but not necessary for ceh-
51 activation. In a tbx-35(tm1789); pop-1(RNAi) background,
expression of ceh-51::GFP became undetectable (Fig. 3L),
suggesting that activation of ceh-51 in a tbx-35 mutant background
is POP-1-dependent.
To test for direct interaction of TBX-35 with ceh-51, we purified
recombinant GST::TBX-35 DNA-binding domain (DBD) expressed
in E. coli, and found that a 187 bp fragment of ceh-51 could be gel
shifted (Fig. 4A, lanes 6-8). We identified four putative TBX-35
binding sites based on similarity to the consensus sequence for the
founding T-box factor Brachyury (Kispert and Herrmann, 1993),
and confirmed that they were protected in a DNase I footprinting
assay (Fig. 4B). These regions define a consensus of
RTSKCACCYNNYY (Fig. 4C), which matches 7/8 sites of the
Brachyury half-site TCACACCT (matches underlined) (Kispert and
Herrmann, 1993). Hence, it is likely that TBX-35 binds DNA as a
monomer, similar to mouse Tbx20 and Tbx5 (Ghosh et al., 2001;
Macindoe et al., 2009; Stennard et al., 2003). A competitor
oligonucleotide containing two of the candidate sites competed the
shifts, whereas a competitor with both sites mutated did not (Fig. 4A,
lanes 9-11), and all four sites appear to be important for TBX-35
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Fig. 2. Structure of ceh-51 and its gene product. (A) Location of ceh-51 and emb-4 exons on LG V. The locations of the mutant alleles tm2123
and tm2187 and the primer pairs A1/A2 and B1/B2 (used to generate overlapping PCR products for rescue of tm2123) are shown. A 3UTR of ~260
bases is predicted by EST yk51g7. Polyadenylation motifs of AATAAA and AATGAA (Hajarnavis et al., 2004) are found 40 bp and 260 bp, respectively,
downstream of the stop codon. tm2123 is a 1610 bp deletion that includes the coding portion of exon 1 and part of exon 2, including the first six
amino acids of the predicted homeodomain, and carries an additional 14 bp insertion. The remainder of the ceh-51 coding region in tm2123 lacks
any in-frame ATG codons, suggesting that tm2123 is null. tm2187 is an intronic 540 bp deletion and was not studied. (B) Comparison of CEH-51 and
other NK-2 proteins. Like all C. elegans NK-2 factors, CEH-51 lacks the Tinman (TN) and NK-2-specific (NK) domains that are found in many other NK-
2 factors (Harvey, 1996). Regions where at least 7/10 contiguous residues are serine are indicated by S. HD, homeodomain. (C) Homeodomain
alignments. Identities with C. elegans CEH-51 are indicated by black boxes and similarities by gray boxes. A tyrosine residue found in NK-2 family
members is indicated with an asterisk (Harvey, 1996). Accession numbers: C. elegans (Ce) CEH-51, CAB60440; CEH-7, AAC36745; CEH-24,
AAB81844; TAB-1 (CEH-29), AAA98021; CEH-22, NP_001076744; C. briggsae CBG20317, CAP37360; Oncorhynchus mykiss (Om) Nkx2.1b,
BAD93686; Mus musculus (Mm) Nkx2.1, NP_033411; Nkx2.5, NP_032726; Drosophila melanogaster (Dm) Vnd, P22808.
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binding (Fig. 4D). In vivo, a minimal ceh-51::GFP reporter carrying
the four sites was expressed in the early MS lineage, its expression
was abolished in a tbx-35(tm1789) background, and mutation of the
sites resulted in a loss of expression (Fig. 4E). We conclude that
TBX-35 directly activates ceh-51.
Overexpressed CEH-51 is sufficient to promote
aspects of MS specification
We next assessed the ability of CEH-51 to specify the development
of MS-derived cell types using a heat-shock (hs) ceh-51 transgene.
Ninety-one percent (n=245) of heat shocked pregastrulation hs-ceh-
51 embryos underwent arrest, whereas heat shock of wild types
resulted in only 22% (n=243) embryonic arrest. We examined
pharynx muscles with ceh-22::GFP (Okkema and Fire, 1994), using
a skn-1(RNAi) background to eliminate MS-derived tissues and AB-
derived pharynx (Bowerman et al., 1992). Among skn-1(RNAi); hs-
ceh-51 embryos, we observed only a small number of ceh-22::GFP-
positive cells following heat shock (Fig. 5F), and were unable to
detect significant expression of the pharynx identity gene pha-4
(Horner et al., 1998) or the pharyngeal myosin gene myo-2 (Miller
et al., 1986) (Fig. 5G; data not shown), suggesting that CEH-51 by
itself has, at most, a weak ability to specify pharynx.
Next, we examined production of muscle in a skn-1(RNAi); pal-
1(RNAi) background, which blocks specification of nearly all body
muscles (Hunter and Kenyon, 1996). In such embryos, hs-ceh-51
was sufficient to promote widespread muscle specification as scored
by unc-120::GFP (Fukushige et al., 2006) and expression of the
body muscle gene myo-3 (Miller et al., 1986) (Fig. 5H,I). Hence,
CEH-51 is sufficient to specify muscle cell fate.
We then examined production of the four embryonically derived
coelomocytes, which arise fairly late in the MS lineage (Sulston et
al., 1983), using cup-4::GFP (Patton et al., 2005). hs-ceh-51 was
sufficient to cause specification of coelomocytes in a skn-1(RNAi)
background, which by itself eliminates them (Table 1; Fig. 5E,F).
We conclude that CEH-51 is sufficient to specify muscle and
coelomocyte precursors. No attempt was made to optimize the time
interval for CEH-51 responsiveness, although under the same
conditions, overexpressed tbx-35 was able to cause specification of
pharynx, muscle and coelomocytes (Broitman-Maduro et al., 2006)
(data not shown).
Loss of ceh-51 function results in defects in MS-
derived tissues
To evaluate the requirement for ceh-51 in MS specification, we
examined ceh-51(RNAi) and ceh-51(tm2123) animals. Gonadal
injection of ceh-51 dsRNA resulted in 47% (n=70) of progeny
arresting as uncoordinated L1 larvae, whereas the remainder
appeared normal (50%) or arrested as early embryos (3%). The
putative null mutant, tm2123 (Fig. 2A), resulted in a fully penetrant
recessive zygotic L1 arrest. This lethality could be rescued by a ceh-
51(+) transgene (see Materials and methods).
We examined ceh-51 mutants for pharynx defects. ceh-
51(tm2123) mutants had a poorly defined metacorpus and an
incompletely developed grinder (Fig. 6A,D), and expression of the
pharynx muscle reporter ceh-22::GFP (Okkema and Fire, 1994) was
observed both inside and outside of the pharynx basement
membrane, suggesting defective pharynx integrity (Fig. 6B,E). We
also observed detachment of the pharynx from the buccal cavity in
64% (n=56) of animals. Similar defects were apparent in ceh-
51(RNAi) arrested larvae (data not shown). ceh-51(tm2123) mutants
also had defects in the organization of actin filaments as detected by
phalloidin staining (Fig. 6C,F). We scored production of all pharynx
cells in ceh-51 mutants using a pha-4::GFP reporter (Horner et al.,
1998), and found that the number of cells in ceh-51 mutants
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Fig. 3. Expression of ceh-51. (A,B) ceh-51 transcripts occur in (A) the MS daughter cells (MS2) and (B) in the MS granddaughters (MS4), as
detected by in situ hybridization. The E daughters are outlined. Ninety-one percent (n=101) of embryos at this stage showed expression in MS2
or MS4 (nine embryos did not stain). (C) Ectopic expression of ceh-51 following heat shock of hs-tbx-35 embryos. (D) Eighty-six percent (n=44)
of pop-1(RNAi) embryos showed ceh-51 mRNA in both the MS and E daughters. Two embryos showed normal expression and four embryos did
not stain. (E) Embryos transgenic for a ceh-51::GFP transcriptional reporter with 788 bp of upstream sequence show expression at MS4 that
persists in later MS descendants. (F) A translational ceh-51::GFP::CEH-51 fusion shows strong nuclear accumulation at MS8. (G) ceh-51::GFP is
undetectable in med-1(ok804); med-2(cx9744) embryos (n=84). (H) Sixty-six percent (n=41) of pop-1(RNAi) embryos showed ceh-51::GFP in
both the MS and E lineages (the remainder were similar to wild type). (I,J) mex-1(RNAi) (I) and pie-1(RNAi) (J) embryos displayed ectopic ceh-
51::GFP in AB and C descendants. (K) In tbx-35(tm1789) embryos, the onset of ceh-51::GFP expression was undetectable (52%, n=89) or
delayed until past the MS8 stage (48%) and at lower levels. The exposure in this image was 10-fold longer than that shown in E. (L) ceh-51::GFP
was not detected in tbx-35(tm1789); pop-1(RNAi) embryos (n=49).
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(47.8±0.9, n=17) was similar to that in wild type (50.0±0.9, n=21,
P=0.1). We compared the pharynx defects in ceh-51 mutants with
those of tbx-35(tm1789) larvae produced at 15°C. Although such
larvae also displayed grinder abnormalities and a defective terminal
bulb, they showed a well-defined metacorpus and less disorganized
muscle actin, although expression of ceh-22::GFP was often mosaic
in posterior pharynx muscle cells (Fig. 6G-I). These results suggest
that ceh-51 primarily affects pharynx development and not
specification.
Next, we examined the production of body muscles using unc-
120::GFP (Fukushige et al., 2006). Seventy-five percent (n=20) of
ceh-51 embryos at the 1.5-fold stage lacked proper expression in the
anterior region of the embryo where MS-derived muscles are
normally found (Fig. 7A,D) (Sulston et al., 1983). Mutants
frequently displayed additional expression of unc-120::GFP
displaced slightly to the posterior, suggesting that muscle cells might
have migration defects (Fig. 7D). As Caudal/PAL-1 is required for
nearly all non-MS body muscles (Hunter and Kenyon, 1996), we
scored muscle cells produced in a pal-1(RNAi) background in wild
type and ceh-51 mutants using hlh-1::GFP (Krause et al., 1994)
(Table 1). ceh-51(tm2123); pal-1(RNAi) embryos made 19.3±0.5
(n=11) hlh-1::GFP cells, slightly less than pal-1(RNAi) alone
(21.6±0.9, n=13, P=0.02). In the case of tbx-35(tm1789); pal-
1(RNAi) at 20°C, the number of muscle cells was much lower
(5.7±0.5, n=40, P=10–4).
We looked for further evidence of defects in muscle development
by combining ceh-51(tm2123) or ceh-51(RNAi) with reduction in
function of one of three factors, HND-1, HLH-1 and UNC-120, that
together define the muscle fate in C. elegans (Fukushige et al.,
2006). Individual loss of function results in mild impairments in
muscle function, but their loss in combination causes a synergistic
failure of muscle specification, resulting in a paralyzed, arrested 2-
fold (Pat) phenotype (Fukushige et al., 2006; Williams and
Waterston, 1994). Loss of ceh-51 synergistically enhanced the
phenotypes of loss of hlh-1, hnd-1 or unc-120 (Fig. 7G).
Individually, RNAi for these factors produced less than 1% Pat
embryos, but in a ceh-51(tm2123) background, 47% Pat resulted
from hlh-1(RNAi) and ~10% Pat from hnd-1(RNAi) or unc-
120(RNAi) (e.g. Fig. 7E); a similar result was observed with ceh-
51(RNAi) (Fig. 7F).
Finally, we observed a decrease in expression of the coelomocyte
marker cup-4::GFP (Patton et al., 2005), from an average of 3.7±0.2
cells (n=105) in wild type to 2.1±0.1 (n=53) in ceh-51(tm2123)
(Table 1), further suggesting that the development of MS
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Fig. 4. TBX-35 binds ceh-51. (A) GST::TBX-35(DBD) shifts a ceh-51 promoter fragment. Competitor oligonucleotides containing two binding sites
competed the shift, whereas a mutant competitor did not. (B) DNase I footprinting of the ceh-51 promoter by GST::TBX-35(DBD) at four regions
(boxed). The thin horizontal line is the join between two autoradiographs. (C) A provisional recognition sequence for TBX-35 (rendered by
WebLogo, http://weblogo.berkeley.edu) resembles that of the Brachyury half-site (Kispert and Herrmann, 1993). (D) TBX-35-dependent shifting of a
187 bp fragment of the ceh-51 promoter as demonstrated with a subset of possible binding site mutants. (E) Expression of a minimal tbx-35-
dependent ceh-51::GFP reporter in a wild-type background, in tbx-35(tm1789), and in a wild-type background in which the reporter has been
mutated at two or more binding sites. At least two transgenic lines and 50 embryos were tested for each promoter.
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descendants is compromised in mutants. Taken together, these
results show that CEH-51 is required for the normal development of
multiple MS tissue types.
TBX-35 and CEH-51 have overlapping function
Loss of med-1,2 results in an embryonic lethal phenotype in which
arrested embryos elongate to between one and two times the length
of the eggshell (Maduro et al., 2007; Maduro et al., 2001). By
contrast, tbx-35 null mutants arrest with varying degrees of
elongation, ranging from 1-fold to complete elongation and hatching
(Broitman-Maduro et al., 2006). These results suggest that TBX-35
works with another factor. Two further observations support this
notion. First, whereas med-1(ok804); med-2(cx9744) double
mutants and skn-1(RNAi) embryos made less than 0.2 coelomocytes
per embryo (Table 1; Fig. 8L), tbx-35(tm1789) embryos raised at
15°C made as many coelomocytes (3.8±0.2, n=28) as wild types
(3.7±0.2, n=105, P>0.9). Second, tbx-35(tm1789) embryos achieved
further elongation overall when raised at 15°C (Fig. 8P). This
increased elongation correlated with an increase in production of
MS-derived pharynx cells as scored by pha-4::GFP in a glp-1(RNAi)
background, which eliminates AB-derived pharynx (Priess et al.,
1987) (Table 1): tbx-35; glp-1(RNAi) embryos at 15°C made 6.6±0.5
pharynx cells (n=23), whereas at 23°C only 1.1±0.3 cells were made
(n=32, P<10–11).
We hypothesized that tbx-35 and ceh-51 double mutants might
show a stronger phenotype than either single mutant, given that ceh-
51 is still activated in tbx-35(tm1789) (Fig. 3K). As shown in Fig. 8
and Table 1, ceh-51(tm2123); tbx-35(tm1789) double mutants
displayed phenotypes that are indistinguishable from med-1(ok804);
med-2(cx9744) (henceforth abbreviated as ceh-51; tbx-35 and med-
1,2). First, ceh-51; tbx-35 double mutants displayed a strong
embryonic arrest that is not temperature sensitive (P=0.48 for 15°C
versus 20°C) (Fig. 8P) and which is comparable to that of med-1,2
double mutants at both temperatures (P=0.36 and P=0.43 for 15°C
and 20°C, respectively). Second, development of MS-derived
pharynx was eliminated in ceh-51; tbx-35 (Table 1; Fig. 8E,F), even
at 15°C, at which single ceh-51 and tbx-35 mutants each displayed
a partial grinder (Fig. 6D,G). Using glp-1(RNAi) to eliminate AB-
derived pharynx, both med-1,2; glp-1(RNAi) and ceh-51; tbx-35;
glp-1(RNAi) embryos made similarly low numbers of pharynx cells
(less than two) as scored with pha-4::GFP or ceh-22::GFP (P=0.15
and P=0.3) (Table 1). Production of pal-1-independent body muscle
cells was reduced in ceh-51; tbx-35; pal-1(RNAi) embryos to levels
comparable to med-1,2; pal-1(RNAi) (P=0.9) (Table 1; Fig. 8H,I).
Lastly, whereas single ceh-51 and tbx-35 mutants made reduced
numbers of cup-4::GFP(+) cells, the double mutants displayed a
synergistic reduction similar to that of a med-1,2 background
(P=0.04) (Table 1; Fig. 8K,L).
MS adopts a C-like fate in med-1,2(RNAi) and skn-1 mutant
embryos (Bowerman et al., 1992; Maduro et al., 2001), but this
transformation is weaker in tbx-35 mutants as zygotic activation of
pal-1 in the MS lineage, a marker of transformation of MS to C
(Baugh et al., 2005), was detected in only ~30% of embryos
(Broitman-Maduro et al., 2006). We found that 75% (n=20) of med-
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Fig. 5. Overexpression of CEH-51 promotes specification of MS-derived cell types. (A,F) A small number of cells expressing ceh-22::GFP are
restored to skn-1(RNAi) embryos by hs-ceh-51. (B,G) Expression of the pharynx muscle gene myo-2 is largely absent in both skn-1(RNAi) and skn-
1(RNAi); hs-ceh-51 embryos. The inset in B shows wild-type expression of myo-2. (C,H) Many hs-ceh-51 embryos display unc-120::GFP-expressing
cells in a skn-1(RNAi); pal-1(RNAi) background, which depletes embryos of nearly all body muscles (Hunter and Kenyon, 1996). (D,I) In a skn-
1(zu67); pal-1(RNAi) background, heat shock of ceh-51 causes the generation of many cells expressing the muscle myosin gene myo-3. One
hundred percent (n=79) of heat shocked non-transgenic embryos resembled those shown in D, whereas 53% (n=53) of heat shocked transgenics
resembled those shown in I. (E,J) hs-ceh-51 embryos accumulate ectopic coelomocytes. (K-M) Bar charts summarizing the hs-ceh-51 data.
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1,2(–) and 60% (n=35) of ceh-51; tbx-35 embryos showed ectopic
zygotic pal-1 mRNA in the early MS lineage (P>0.3) (Fig. 8N,O).
We examined the fate of MS descendants in tbx-35; ceh-51 double
mutants carrying a reporter fusion for nhr-25, a C-lineage gene that
is expressed in hypodermal precursors and their descendants
(Baugh et al., 2005), using a laser to ablate all other cells. Partial
embryos resulting from isolated wild-type MS blastomeres failed
to show significant nhr-25::YFP (n=3), whereas 9/9 MS
blastomeres from tbx-35; ceh-51 double mutants, and 5/5 isolated
C blastomeres from wild types, generated nhr-25::YFP
descendants. Hence, ceh-51; tbx-35 embryos show a strong
transformation of MS to C, suggesting that CEH-51 and TBX-35
together account for the majority of normal MS lineage
development downstream of MED-1,2.
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Table 1. MS-dependent tissues produced in wild-type and mutant embryos
Pharynx cells† Pharynx muscles‡ Muscle cells Coelomocytes
Genotype (pha-4::GFP) (ceh-22::GFP) (hlh-1::GFP) (cup-4::GFP)
Wild type 50.0±0.9 (21) 12.8±0.1 (37) 44.7±1.1 (20) 3.7±0.2 (105)
skn-1(RNAi) 4.8±0.4 (20) 0.0±0.0 (165) nd 0.15±0.04 (124)
pal-1(RNAi) 49.5±0.8 (10) 11.7±0.3 (12) 21.6±0.9 (13) 3.7±0.1 (103)
pop-1(RNAi) nd nd nd 0.0±0.0 (50)
glp-1(RNAi) 23.1±0.6 (15) 5.7±0.2 (38) nd nd
tbx-35(tm1789) 15°C 40.6±1.2 (17) 5.9±0.3 (24) 37.3±1.6 (10) 3.8±0.2 (28)
tbx-35(tm1789) 23°C 35.7±0.8 (16)** 5.2±0.2 (46)* 34.8±2.4 (10) 3.3±0.4 (20)
tbx-35(tm1789); glp-1(RNAi) 15°C 6.6±0.5 (23) 2.0±0.4 (26) nd nd
tbx-35(tm1789); glp-1(RNAi) 23°C 1.1±0.3 (32)** 1.0±0.2 (39)* nd nd
tbx-35(tm1789); pal-1(RNAi) 15°C 38.8±0.7 (15) 5.1±0.3 (14) 8.4±1.0 (17) 2.2±0.2 (47)
tbx-35(tm1789); pal-1(RNAi) 23°C 35.6±1.0 (14)* 4.7±0.3 (17) 5.7±0.5 (40)* 0.6±0.1 (49)**
ceh-51(tm2123) 47.8±0.9 (17) 9.2±0.2 (10) 42.4±1.4 (10) 2.1±0.1 (53)
ceh-51(tm2123); pal-1(RNAi) nd nd 19.3±0.5 (11) 2.5±0.1 (84)
med-1(ok804); med-2(cx9744) 31.3±0.6 (26) 4.1±0.2 (32) 31.0±2.7 (10) 0.07±0.03 (34)
ceh-51(tm2123); tbx-35(tm1789) 30.2±0.5 (44) 4.4±0.2 (18) 30.1±1.0 (14) 0.19±0.04 (124)*
med-1(ok804); med-2(cx9744); glp-1(RNAi) 1.4±0.4 (14) 0.3±0.1 (31) nd nd
ceh-51(tm2123); tbx-35(tm1789); glp-1(RNAi) 1.9±0.5 (26) 0.5±0.1 (52) nd nd
med-1(ok804); med-2(cx9744); pal-1(RNAi) nd nd 3.8±0.5 (13) nd
ceh-51(tm2123); tbx-35(tm1789); pal-1(RNAi) nd nd 3.9±0.4 (15) nd
Strains were grown at 20-23°C unless otherwise indicated. Data are shown as the mean ± s.e.m. *0.01<P<0.05, **P<0.01, Student’s t-test, by comparison with the
experiment immediately above. nd, not done.
†Only pharynx expression of pha-4::GFP, anterior to the gut (when present), was scored.
‡The anatomy of the pharynx was considered in assigning expression to particular muscle cells.
Fig. 6. ceh-51 mutants and tbx-35 mutants raised at 15°C arrest as larvae with pharynx structural defects. Pharynxes were visualized by
DIC optics (A,D,G), ceh-22::GFP expression (B,E,H) (Okkema and Fire, 1994) or phalloidin staining (C,F,I) (Franks et al., 2006). In the DIC panels, the
lumen (arrows), grinder (gr), metacorpus (mc) and terminal bulb (tb) are indicated and the pharynx is outlined (dashed line). (A-C) Wild-type
pharynx. (D-F) ceh-51(tm2123) pharynxes show lumen irregularities and an indistinct metacorpus (D). Protrusions accumulate GFP outside the
pharynx, suggesting a defect in pharynx integrity (E). In F, phalloidin staining shows actin filament accumulations (large arrowheads), lumen
abnormalities (small arrowheads) and an abnormal terminal bulb (arrow). (G-I) tbx-35(tm1789) raised at 15°C has a normal lumen but abnormal
grinder (G). ceh-22::GFP expression (H) shows absence of expression of ceh-22::GFP in part of the posterior pharynx (arrowhead); contralateral
expression in this region is likely to be in an MS-derived m7 muscle (Okkema and Fire, 1994; Sulston et al., 1983). In I, phalloidin staining shows
some actin accumulations (arrowhead) and an abnormal terminal bulb (arrow). D
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DISCUSSION
New regulatory interactions in the MS gene
network
We have identified a new regulator, CEH-51, in MS specification.
Our results suggest that TBX-35 and CEH-51 could participate in a
‘feed-forward’ regulatory cascade (Lee et al., 2002), in which TBX-
35 activates ceh-51, and both TBX-35 and CEH-51 activate
common target genes in MS development. There is likely to be at
least one other MS lineage activator of ceh-51 because a ceh-
51::GFP reporter was still weakly expressed in a tbx-35 null
background (Fig. 3K). Whereas pal-1(RNAi) reduced coelomocyte
production in tbx-35(tm1789) mutants (Table 1), there was no effect
on ceh-51::GFP expression (data not shown). Instead, this activator
appears to be downstream of POP-1 because simultaneous loss of
pop-1 and tbx-35 resulted in loss of ceh-51::GFP expression (Fig.
3L). We also observed ectopic expression of ceh-51 in the early E
lineage in pop-1(RNAi) embryos (Fig. 3D,H), suggesting that POP-
1 might contribute to repression of ceh-51 in the E lineage. The
observation that a tbx-35; pop-1 background abolishes all ceh-
51::GFP expression suggests that ectopic TBX-35 is responsible for
E lineage expression of ceh-51 in pop-1(RNAi). Although we failed
to detect activation of tbx-35 in E in pop-1(–) embryos (Broitman-
Maduro et al., 2006), such ectopic expression of tbx-35::GFP has
been observed by others (P. Shetty and R. Lin, personal
communication). We have recently shown that in the related
nematode C. briggsae, POP-1 contributes positively to MS
specification in parallel with SKN-1, and there is an apparent
function for POP-1 in repression of the MS fate in E (Lin et al.,
2009). Hence, these additional roles for POP-1 might be
evolutionarily conserved.
Shared and distinct functions for CEH-51 and
TBX-35
Although ceh-51(tm2123); tbx-35(tm1789) embryos have a
synergistic phenotype compared with the single mutants, each gene
has unique essential functions, as evidenced by their distinct
phenotypes (Figs 6 and 7). Overexpressed CEH-51 was sufficient to
promote specification of muscle and coelomocytes, but was
apparently not as effective at promoting pharynx development (Fig.
5), whereas overexpressed TBX-35 could specify all three tissues
efficiently (Broitman-Maduro et al., 2006) (data not shown).
Conversely, ceh-51(tm2123) mutants had only mild defects in
pharynx, muscle and coelomocytes, whereas tbx-35(tm1789)
mutants had strong defects in pharynx and muscle at 20°C
(Broitman-Maduro et al., 2006) (Table 1). At 15°C, ceh-51 is able
to partially rescue these defects, resulting in a higher proportion of
elongated animals and more normal specification of MS-derived
tissues (Table 1). Hence, CEH-51 adds robustness to MS
specification primarily at lower temperatures. In the future,
identification of TBX-35 and CEH-51 target genes might explain
the basis for their different activities, perhaps accounting for why
CEH-51 does not rescue aspects of MS specification in tbx-35
mutants at higher temperatures. We have identified putative TBX-
35 binding sites in the promoters of hlh-1 and pha-4 (W.W.K.H. and
M.F.M., unpublished), although we have not yet identified common
targets for both TBX-35 and CEH-51.
Collaboration of T-box and NK-2 factors in
mesoderm development
The apparent collaboration of TBX-35 and CEH-51 in C. elegans
mesoderm development, downstream of MED-1,2, is highly
reminiscent of the roles of related factors involved in cardiac
development in other systems. In C. elegans, the pharynx is the
structure that most closely resembles the heart, as it is a contractile
pumping organ that expresses unique sets of myosins (Mango,
2007; Okkema et al., 1993). Expression of vertebrate Nkx2.5 is
able to compensate for loss of ceh-22 in the C. elegans pharynx,
suggesting a common evolutionary origin of heart and pharynx
(Haun et al., 1998). Here, we have shown that TBX-35 and CEH-
51 have both distinct and shared roles in pharynx progenitor
specification and development. The Drosophila Nkx2.5 ortholog
tinman is important for defining early domains that are restricted
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Fig. 7. Muscle defects in ceh-51(tm2123). (A,D) Loss
of MS-derived unc-120::GFP expression (arrowheads) in
ceh-51 (D) as compared with wild type (A). Additional
expression is indicated by small arrows. (B,C,E,F) Loss of
ceh-51 synergizes with partial muscle specification
mutants to produce paralyzed, arrested 2-fold (Pat)
embryos. Whereas more than 95% of hlh-1(cc561ts)
mutants grown at 15°C (B), and more than 99% of ceh-
51(tm2123) embryos (C), elongated to greater than 3-
fold, between 47 and 49% of embryos produced by a
combination of mutation of ceh-51 with RNAi of hlh-1
(E), or vice versa (F), produced a synthetic Pat phenotype.
(G) Summary of synthetic Pat phenotypes. Data are
shown as the percentage of progeny arresting as embryos
(%Emb)/percentage of progeny arresting as paralyzed, 2-
fold (Pat) embryos (%Pat) (included in the Emb totals).
Backgrounds have been shaded to indicate higher %Pat.
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to forming heart, visceral muscle and some body muscles, as
mutants have impairments in the development of these tissues
(Azpiazu and Frasch, 1993; Bodmer, 1993). Activation of tinman
in cardioblasts requires the T-box genes midline and H15 (Reim et
al., 2005). In Xenopus, the T-box factor Tbx5 is expressed in heart
precursors and is known to be essential for heart development
(Horb and Thomsen, 1999). Similarly, Nkx2.5 is expressed in early
cardioblasts (Lints et al., 1993) and plays an important role in heart
patterning, as Nkx2.5 knockout mice show heart defects (Lyons et
al., 1995). Finally, mouse Tbx5 and Nkx2.5 physically interact and
collaborate with Gata4/5 in synergistic activation of cardiac genes
(Bruneau et al., 2001; Hiroi et al., 2001; Stennard et al., 2003).
Hence, the collaboration between TBX-35 and CEH-51 in C.
elegans might be evolutionarily conserved. Future work aimed at
elucidating the gene network downstream of TBX-35 and CEH-51
might uncover further conserved aspects of cardiac and mesoderm
development.
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Fig. 8. Mutation of ceh-51 and tbx-35 together
synergizes to a med-1,2(–) arrest phenotype.
(A-C) Pharynx muscles marked by ceh-22::GFP
(Okkema and Fire, 1994) overlaid on DIC images.
(A) Arrested 1.5-fold tbx-35(tm1789) embryo raised at
20°C showing AB-derived and MS-derived pharynx
muscles. (B) ceh-51(tm2123); tbx-35(tm1789) double
mutant arrested at ~1.5-fold elongation. (C) med-
1(ok804); med-2(cx9744) double mutant.
(D-F) Polarized light images to show gut granules
overlaid with pha-4::GFP (Horner et al., 1998). (D) At
15°C, tbx-35(tm1789); glp-1(RNAi) embryos display
6.6±0.5 (n=23) pharynx cells. Some additional GFP-
positive cells are seen (arrows); similar ‘stray’ GFP
expression is also seen in a skn-1(RNAi) background
(see Table 1). Gut/rectum expression of pha-4::GFP
coincides with birefringence of gut granules, which
mark the intestine. (E) ceh-51(tm2123); tbx-
35(tm1789); glp-1(RNAi) embryo showing a small
number of pharynx cells (arrow). (F) med-1(ok804);
med-2(cx9744); glp-1(RNAi) embryo. (G-I) Body muscle
cells marked by hlh-1::GFP (Krause et al., 1990).
(G) Wild-type embryo just before hatching. (H) ceh-
51(tm2123); pal-1(RNAi) embryo. (I) ceh-51(tm2123);
tbx-35(tm1789); pal-1(RNAi) embryo.
(J-L) Coelomocytes marked by cup-4::GFP (Patton et
al., 2005). (J) Wild-type embryo with four
coelomocytes. (K,L) Double ceh-51(tm2123); tbx-
35(tm1789) or med-1(ok804); med-2(cx9744) mutants
produce little or no coelomocytes. (M) In situ
hybridization showing expression of pal-1 in the early
C and D lineages (Baugh et al., 2005). (N) Ectopic
expression of pal-1 in ceh-51(tm2123); tbx-35(tm1789)
double mutant. (O) Ectopic pal-1 in a med-1(ok804);
med-2(cx9744) embryo. (P) Histogram summarizing
elongation of wild-type and mutant embryos. *,
P=0.05 (χ2 test), for some dataset pairs (comparisons
among other pairs are not shown). The total number
(n) of embryos scored per experiment is shown above
each bar.
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